Back to ExodusPoint Capital Management, LP ExodusPoint Capital Management, LP

NGNE

Showing 3 of 6 quarters

Position history for ExodusPoint Capital Management, LPExodusPoint Capital Management, LP's holdings in Neurogene Inc.

No. ExodusPoint Capital Management exited its NGNE (Neurogene) position in Q1 2026. Its Q4 2025 13F listed 29,119 shares worth $599,851. ExodusPoint Capital Management first reported NGNE in Q4 2023 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$563,589

Total Shares Change

-32,521

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$21.99
0
2025-Q4
Decreased
29,119
-10.5%
$599,8510.0%$22.11
0
2025-Q3
New
32,521
-
$563,5890.0%$17.71
34

Other major holders of NGNE: BlackRock, Inc., BlackRock Finance, Inc., RTW Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used